The use of high-throughput technologies for single B cell screening offers numerous advantages over traditional hybridoma technology in the discovery of lead therapeutic antibodies. Hybridoma ...
Credit: Guardant. Guardant Health’s Shield blood test is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood. The Shield test is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback